Brief: BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission
23/09/2026 14:48
BRIEF-BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission Sept 23 (Reuters) - BioCardia Inc BCDA.O:
BIOCARDIA CONFIRMS TIMING AND PROVIDES UPDATE ON FDA HELIX PRE-SUBMISSION AND PMDA CARDIAMP HF SHONIN SUBMISSION
BIOCARDIA - TO SUBMIT SHONIN PRE-MARKET APPLICATION TO PMDA IN Q4 2026
BIOCARDIA - MARKET CLEARANCE FOR CARDIAMP IN JAPAN POSSIBLE BY Q4 2027
BIOCARDIA - TO SUBMIT DE NOVO PRE-SUBMISSION FOR HELIX CATHTER SYSTEM TO FDA THIS QUARTER
Source text: ID:nGNX1sCkPv
Further company coverage: BCDA.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on BioCardia
See all newsBrief: BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission
BioCardia Inc reports results for the quarter ended June 30 - Earnings Summary
BioCardia Q2 net loss narrows on lower R&D costs
Brief: BioCardia, Inc. Q2 Net Income USD -1.613 Million
BioCardia Inc expected to post a loss of 18 cents a share - Earnings Preview